{"database": "lobbying", "table": "lobbying_activities", "rows": [[2608888, "3c76de19-51d2-4017-b0be-a4813bd93477", "Q1", "BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC", 292972, "BOEHRINGER INGELHEIM USA CORPORATION", 2021, "first_quarter", "ANI", "Compounding Animal Drugs from Bulk Substances; Draft Guidance for Industry (FDA) - FDA-2018-D-4533\nIssues related to veterinary telehealth\nIssues related to rural broadband\nIssues related to One Health", "Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE", null, 1160000, 0, 0, "2021-04-20T08:44:45.617000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2608888"], "units": {}, "query_ms": 2.3638729471713305, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}